Hiroshi Ureshino

44PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursLiquid biopsiesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Sep 11, 2026
Road to treatment-free remission in chronic myeloid leukemia.

|Jan 07, 2026
Specifically targeting the ABL myristoyl pocket: STAMP inhibitors for chronic myeloid leukemia.

Hiroshi Ureshino, Shinya Kimura

|Dec 18, 2024
IFN-α treatment may enable discontinuation of TKIs in NK cell-licensed patients with CML-CP.

Hiroshi Ureshino, Kazuharu Kamachi, Keisuke Kidoguchi

|Jul 25, 2024
A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment.

Hiroshi Ureshino, Yusuke Takeda, Kazuharu Kamachi

|Nov 25, 2023
Efficacy of Low-Level Laser Therapy for Oral Mucositis in Hematologic Patients Undergoing Transplantation: A Single-Arm Prospective Study.

Hiromi Nishi, Susumu Horikoshi, Kouji Ohta

|Oct 28, 2023
A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation.

Kazunori Kawasoe, Tatsuro Watanabe, Nao Yoshida-Sakai

Pageof 8

Frequent Collaborators

6 joint publications

Shinya Kimura

4 joint publications

Kazuharu Kamachi

3 joint publications

Tatsuro Watanabe

3 joint publications

Nao Yoshida-Sakai